default author photo

Johan Verbeeck

Interuniversity Institute for Biostatistics and statistical Bioinformatics (IBioStat) - Data Science Institute

SCHOLARLY PAPERS

1

DOWNLOADS

114

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Digital Tool to Contextualise the Benefit Risk of COVID-19 Vaccines in the European Union: The Benefit Risk Assessment of Vaccines (BRAVE) Toolkit

Number of pages: 31 Posted: 27 Jun 2023
European Medicines Agency, Interuniversity Institute for Biostatistics and statistical Bioinformatics (IBioStat) - Data Science Institute, Interuniversity Institute for Biostatistics and statistical Bioinformatics (IBioStat) - Data Science Institute, European Medicines Agency, Interuniversity Institute for Biostatistics and statistical Bioinformatics (IBioStat) - Data Science Institute, European Medicines Agency, University of Antwerp - Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Interuniversity Institute for Biostatistics and statistical Bioinformatics (IBioStat) - Data Science Institute, Interuniversity Institute for Biostatistics and statistical Bioinformatics (IBioStat) - Data Science Institute, European Medicines Agency, European Medicines Agency and Interuniversity Institute for Biostatistics and statistical Bioinformatics (IBioStat) - Data Science Institute
Downloads 114 (630,858)

Abstract:

Loading...

benefit risk contextualisation, interactive tool, multi-country perspective, modelling